Patents Assigned to InteKrin Therapeutics, Inc.
  • PPAR? agonists for treatment of multiple sclerosis
    Patent number: 9867816
    Abstract: Methods of treatment of multiple sclerosis (MS) with PPAR? agonists, and in particular with the compound of formula (I) known as INT131:
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: January 16, 2018
    Assignee: InteKrin Therapeutics, Inc.
    Inventor: David Weinstein
  • Solid pharmaceutical compositions of ppary modulator
    Patent number: 9675603
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-? suitable for oral dosage to treat subjects having PPAR-? mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-? mediated condition.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: June 13, 2017
    Assignee: InteKrin Therapeutics, Inc.
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear
  • PPAR gamma agonists for treatment of multiple sclerosis
    Patent number: 9539249
    Abstract: Methods of treatment of multiple sclerosis (MS) with PPAR? agonists, and in particular with the compound of formula (I) known as INT131:
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: January 10, 2017
    Assignee: Intekrin Therapeutics, Inc.
    Inventor: David Weinstein
  • PPAR gamma agonists for treatment of multiple sclerosis
    Patent number: 9061020
    Abstract: Methods of treatment of multiple sclerosis (MS) with PPAR? agonists, and in particular with the compound of formula (I) known as INT131:
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: June 23, 2015
    Assignee: InteKrin Therapeutics, Inc.
    Inventor: David Weinstein
  • PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20140213612
    Abstract: Methods of treatment of multiple sclerosis (MS) with PPAR? agonists, and in particular with the compound of formula (I) known as INT131:
    Type: Application
    Filed: January 23, 2014
    Publication date: July 31, 2014
    Applicant: InteKrin Therapeutics, Inc.
    Inventor: David Weinstein
  • Antidiabetic Solid Pharmaceutical Compositions
    Publication number: 20130243865
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-Y suitable for oral dosage to treat subjects having PPAR-Y mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-Y mediated condition.
    Type: Application
    Filed: September 19, 2011
    Publication date: September 19, 2013
    Applicant: Intekrin Therapeutics, Inc., INC.
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear